Cybin Inc. (CYBN) Financials
CYBN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 97.8 million | 6.4 million |
| 2023-09-30 | 42.4 million | 6.8 million |
| 2023-06-30 | 56.3 million | 4.8 million |
| 2023-03-31 | 39.8 million | 4.2 million |
CYBN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -19.8 million | 7.5 million |
| 2023-09-30 | -8.6 million | 1.0 million |
| 2023-06-30 | -8.6 million | 1.6 million |
| 2023-03-31 | -8.2 million | 355529 |
CYBN Net Income
No data available :(
CYBN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 29.4 million | - | 275945 |
| 2023-09-30 | 13.3 million | - | - |
| 2023-06-30 | 32.3 million | - | - |
| 2023-03-31 | 12.3 million | - | - |
CYBN Shares Outstanding
CYBN Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 129679 | 5.6 million | 14.6 million | 17340 |
| 2023-09-30 | 189838 | 5.1 million | 5.1 million | 11037 |
| 2023-06-30 | 157123 | 4.6 million | 5.0 million | 538599 |
| 2023-03-31 | 161133 | 6.0 million | 4.1 million | 8869 |
CYBN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | - | 107060 |
| 2023-09-30 | - | 52242 |
| 2023-06-30 | - | 52122 |
| 2023-03-31 | - | 50261 |
CYBN
Price: $0.35
52 week price:
Earnings Per Share: -0.22 USD
P/E Ratio: -1.83
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Volume: 1.6 million
Market Capitalization: 288.6 million